Cargando…
Optimizing drug selection from a prescription trajectory of one patient
It is unknown how sequential drug patterns convey information on a patient’s health status and treatment guidelines rarely account for this. Drug-agnostic longitudinal analyses of prescription trajectories in a population-wide setting are needed. In this cohort study, we used 24 years of data (1.1 b...
Autores principales: | Aguayo-Orozco, Alejandro, Haue, Amalie Dahl, Jørgensen, Isabella Friis, Westergaard, David, Moseley, Pope Lloyd, Mortensen, Laust Hvas, Brunak, Søren |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8528868/ https://www.ncbi.nlm.nih.gov/pubmed/34671068 http://dx.doi.org/10.1038/s41746-021-00522-4 |
Ejemplares similares
-
Reply to: Immortal time bias in the analysis of drug prescription trajectories
por: Mortensen, Laust Hvas, et al.
Publicado: (2022) -
Disease trajectory browser for exploring temporal, population-wide disease progression patterns in 7.2 million Danish patients
por: Siggaard, Troels, et al.
Publicado: (2020) -
Drug dosage modifications in 24 million in-patient prescriptions covering eight years: A Danish population-wide study of polypharmacy
por: Leal Rodríguez, Cristina, et al.
Publicado: (2023) -
Age‐stratified longitudinal study of Alzheimer's and vascular dementia patients
por: Jørgensen, Isabella Friis, et al.
Publicado: (2020) -
Phenome‐Wide Analysis of Short‐ and Long‐Run Disease Incidence Following Recurrent Pregnancy Loss Using Data From a 39‐Year Period
por: Westergaard, David, et al.
Publicado: (2020)